SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Slugger who wrote (7297)9/24/1998 7:40:00 AM
From: opalapril  Read Replies (1) of 17367
 
Thanks. I get it. This is a little like Kremlinology in the old days, isn't it? I was rattled by the reference to some sort of redesign of the P-3. Your message underscores for me another point which I take could be very bullish. The DSMB requested the meeting not for a specific date, it would seem, but >>shortly before completion of enrollment<<

I suppose that could be the key. If the DSMB was seeing efficacy problems they probably wouldn't much care when they meet next and might as well do it at trial's end, December as planned. If efficacy looks promising, I suppose they could wish to be in a position to recommend halt of the placebo.

Still, that darn alternative of redesign tickles my scalp. Whaaa?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News